Black patients may experience less vision improvement after bevacizumab for DME

• Posted on: Jun 11 2021
• By: Saratoga Opthalmology
• Leave a response

This retrospective cohort analysis examined the impact of race and ethnicity on the efficacy of intravitreal bevacizumab for diabetic macular edema (DME).
Source: AAO

Posted in: Uncategorized